Neurotrophin-3: AMGN plans to begin a trial in the U.S. and Canada

Amgen Inc. (AMGN), Thousand Oaks, Calif. Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: Neurotrophin-3 (NT-3) Indication: Peripheral neuropathy caused by diabetes Status: AMGN, on ...